PCV126 - Cost-Effectiveness Of Edoxaban Compared With Other Licensed Noacs For The Prevention Of Stroke And Systemic Embolic Events In The Uk
| Autor: | Claxton, L, Taylor, M, Lewis, L, Alexandre, AF, Harrington, AE, Bakhai, A, Brueggenjuergen, B |
|---|---|
| Zdroj: | In Value in Health November 2015 18(7):A396-A396 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect